Investor Presentaiton
III Sustainability of Growth and Margin Profile
A
Enhancing Profitability
Economies of Scale
Favorable Cost Structure
ISP's CoGs is mainly the cost of medicine bought, all other operational
costs are allocated to SG&A, with c.60% being fixed costs
4.6%
4.5%
4.3%
4.1%
Drop in SG&A % of Sales on the back of
economies of scales
2015
c. 60%
2016
2017
2018
c.60% Fixed Costs as of
2019
ā Well Defined Expansion Plan
ISP's fixed costs shall be diluted as a result of the anticipated expansion
plans through widening the distribution centers reach, thus minimizing
number of drops and aggregating delivery volumes
Distribution Centers Evolution
+4
+3
+6
62
+7
59
+4
55
49
+8
42
38
30
2013
2014 2015 2016 2017
2018
2019 2020 2021
2022
Revenue CAGR (15-19)
+31%
ibnsinapharma
B
Efficient Business Model
Fully Automated Supply Chain
ibnsina harma
Mobile Racks
Order Picking
Fleet Tracking
Well invested technology in supply chain enhance the operational
efficiency of the business hence reflecting on the profitability margins
Increased Productivity and Efficiency
226
174
150
129
113
20
16
9
10
Rev. per DC (EGP mn)
14
Rev. per vehicle (EGP mn)
Seasoned management and track record of operational excellence,
reflect on the productivity of ISP's employees, vehicles and sites
GPM (15/19)
7.3% / 8.7%
GPM CAGR (15-19)
+38%
EBITDA Margin (15/19)
2.9% / 4.5%
EBITDA CAGR (15 - 19)
+52%
Source: EIU, Company Management
29View entire presentation